MaxCyte
(NASDAQ) MXCT
MaxCyte Financials at a Glance
Market Cap
$111.14M
Revenue (TTM)
$32.29M
Net Income (TTM)
$39.12M
EPS (TTM)
$-0.37
P/E Ratio
-2.83
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$1.03
Volume
22,492
Open
$1.07
Price
$1.03
Volume
22,492
Open
$1.07
Previous Close
$1.03
Daily Range
$1.01 - $1.07
52-Week Range
$0.64 - $2.40
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$1.03
Volume
22,492
Open
$1.07
Previous Close
$1.03
Daily Range
$1.01 - $1.07
52-Week Range
$0.64 - $2.40
MXCT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MaxCyte
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
91
CEO
Maher Masoud
Website
www.maxcyte.comHeadquarters
Rockville, MD 20850, US
MXCT Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-21%
Return on Capital
-21%
Return on Assets
-20%
Earnings Yield
-35.34%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$111.14M
Shares Outstanding
106.86M
Volume
22.49K
Avg. Volume
1.01M
Financials (TTM)
Gross Profit
$26.80M
Operating Income
$45.28M
EBITDA
$40.14M
Operating Cash Flow
$34.41M
Capital Expenditure
$1.77M
Free Cash Flow
$36.18M
Cash & ST Invst.
$103.04M
Total Debt
$17.94M
MaxCyte Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.65M
-7.1%
Gross Profit
$7.07M
-20.5%
Gross Margin
73.22%
N/A
Market Cap
$111.14M
N/A
Market Cap/Employee
$974.87K
N/A
Employees
114
N/A
Net Income
$4.75M
+53.7%
EBITDA
$5.14M
+53.4%
Quarterly Fundamentals
Net Cash
$2.93M
-102.5%
Accounts Receivable
$4.25M
-23.1%
Inventory
$7.63M
-7.8%
Long Term Debt
$16.11M
-8.2%
Short Term Debt
$1.37M
+7.7%
Return on Assets
-20.12%
N/A
Return on Invested Capital
-20.98%
N/A
Free Cash Flow
$8.39M
+44.3%
Operating Cash Flow
$8.17M
+43.3%